Option Care Health, Inc. (OPCH) FY2025 10-K Annual Report
Option Care Health, Inc. (OPCH) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 24, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
Option Care Health, Inc. FY2025 10-K Analysis
Business Overview
- • Core business: Largest independent provider of home and alternate site infusion therapy via 196 locations in 43 states, serving complex chronic conditions
- • New emphasis: Expansion of ambulatory infusion suites to 109 standalone locations, including 27 with advanced practitioner capabilities
Management Discussion & Analysis
- • Revenue $5.65B, up 13.0% YoY from $5.00B driven by mid-teens growth in acute therapies and low double-digit chronic growth
- • Operating margin declined to 6.0% from 6.4%; gross margin fell to 19.3% from 20.3% due to therapy mix and biosimilar adoption
Risk Factors
- • No specific or timely risk factors disclosed in provided text
Option Care Health, Inc. FY2025 Key Financial MetricsXBRL
Revenue
$5.6B
▲ +15.0% YoY
Net Income
$208M
▼ -2.0% YoY
Gross Margin
19.3%
▼ -137bp YoY
Operating Margin
6.0%
▼ -57bp YoY
Net Margin
3.7%
▼ -64bp YoY
ROE
15.7%
▲ +57bp YoY
Total Assets
$3.5B
▲ +1.0% YoY
EPS (Diluted)
$1.27
▲ +3.3% YoY
Operating Cash Flow
$258M
▼ -20.1% YoY
Source: XBRL data from Option Care Health, Inc. FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Option Care Health, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.